Terbium-sensitized fluorescence method for the determination of deferasirox in biological fluids and tablet formulation

Luminescence

Volumn 26, Issue 4, 2011, Pages 244-250

  Manzoori, Jamshid L ^a   Jouyban, Abolghasem ^b   Amjadi, Mohammad ^a   Panahi Azar, Vahid ^a   Tamizi, Elnaz ^c   Vaez Gharamaleki, Jalil ^d  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

deferasirox; fluorescence; serum; terbium sensitized luminescence; urine

Indexed keywords

BODY FLUIDS; TERBIUM;

BIOLOGICAL FLUIDS; DEFERASIROX; FLUORESCENCE METHOD; LIMIT OF DETECTION; REPRODUCIBILITIES; SENSITIZED FLUORESCENCE; SERUM; TABLET FORMULATIONS; TERBIUM-SENSITIZED LUMINESCENCE; URINE;

FLUORESCENCE;

EID: 79551561569     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.1218     Document Type: Article

References (14)

1. Cappellini MD,. Exjade (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther Clin Risk Manag 2007; 3: 291-9. (Pubitemid 46881456)
2. Debebe Z, Ammosova T, Jerebtsova M, Kurantsin-Mills J, Niu X, Charles S, Richardson DR, Ray PE, Gordeuk VR, Nekhai S,. Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology 2007; 367: 324-33. (Pubitemid 47494537)
3. Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE, Spellberg BJ,. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007; 117: 2649-57. (Pubitemid 47494365)
4. Rouan MC, Buffet C, Masson L, Marfil F, Humbert H, Maurer G,. Practice of solid-phase extraction and protein precipitation in the 96-well format combined with high-performance liquid chromatography-ultraviolet detection for the analysis of drugs inplasma and brain. J Chromatogr B 2001; 754: 45-55. (Pubitemid 32241067)
5. Rouan MC, Marfil F, Mangoni P, Sechaud R, Humbert H, Maurer G,. Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection. J Chromatogr B 2001; 755: 203-13. (Pubitemid 32324086)
6. Rouan MC, Buffet C, Marfil F, Humbert H, Maurer G,. Plasma deproteinization by precipitation and filtration in the 96-well format. J Pharm Biomed Anal 2001; 25: 995-1000. (Pubitemid 32488966)
7. Bruin GJM, Faller T, Wiegand H, Schweitzer A, Nick H, Schneider J, Boernsen KO, Waldmeier F,. Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats. Drug Metabol Dispos 2008; 36: 2523-38.
8. Hajjizadeh M, Jabbari A, Heli H, Moosavi-Movahhedi AA, Shafiee A, Karimian K,. Electrocatalytic oxidation and determination of deferasirox and deferiprone on a nickel oxyhydroxide-modified electrode. Anal Biochem 2008; 373: 337-48.
9. Ioannou PC, Rusakova NV, Andrikopoulou DA, Glynou KM, Tzompanaki GM,. Spectrofluorimetric determination of anthranilic acid derivatives based on terbium sensitized fluorescence, Analyst 1998; 123: 2839-43. (Pubitemid 29027313)
10. Gunnlaugsson T, Leonard JP,. Responsive lanthanide luminescent cyclen complexes:from switching/sensing to supramolecular architectures. Chem Commun 2005; 3114-31. (Pubitemid 41002372)
11. Yegorova AV, Scripinets YV, Duerkop A, Karasyov AA, Antonovich VP, Wolfbeis OS,. Sensitive luminescent determination of DNA using the terbium(III)-difloxacin complex. Anal. Chim. Acta 2007; 584: 260-7. (Pubitemid 46172447)
12. 3+ as a fluorescence probe by spectrofluorimetry. J Lumin 2006; 116: 67-72. (Pubitemid 41525729)
13. Templeton EF, Wong HE, Evangelista RA, Granger T, Pollak A,. Time-resolved fluorescence detection of enzyme-amplified lanthanide luminescence for nucleic acid hybridization assays. Clin Chem 1991; 37: 1506-12. (Pubitemid 21905206)
14. Henry JB,. Todd-Sanford-Davidson: Clinical Diagnosis and Management by Laboratory Methods, 18th edn, Saunders, Philadelphia, PA, 1990.